Cabot Corp. Stock
Cabot Corp. shows a slight decrease today, losing -€0.350 (-0.470%) compared to yesterday.
Our community is currently high on Cabot Corp. with 4 Buy predictions and 2 Sell predictions.
However, we have a potential of -20.59% for Cabot Corp. as the target price of 59 € is below the current price of 74.3 €.
Pros and Cons of Cabot Corp. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cabot Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cabot Corp. | -0.470% | 1.503% | 13.783% | 12.576% | 32.679% | 6.906% | 40.189% |
| Innospec Inc. | -0.710% | -1.418% | 7.752% | -5.442% | 5.303% | -25.269% | - |
| Sensient Technologies Corp. | -1.540% | -4.950% | -1.031% | 17.791% | 20.000% | 34.266% | - |
| Stepan Co | -0.450% | -3.043% | 6.190% | -2.620% | 12.060% | -47.836% | -59.083% |
Comments
Cabot (CBT) had its price target raised by JPMorgan Chase & Co. from $68.00 to $70.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for CBT provided by MarketBeat
Cabot (NYSE:CBT) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Show more
Ratings data for CBT provided by MarketBeat
Cabot (NYSE:CBT) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Show more
Ratings data for CBT provided by MarketBeat
News
Why a Fund Made a $3.5 Million Bet on This Flat Chemicals Stock With Declining Revenue and Earnings
On April 22, 2026, 1492 Capital Management disclosed a new position in Cabot Corporation (NYSE:CBT), acquiring 48,057 shares in the first quarter. The estimated transaction value was $3.49 million
